CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed
Drug / intervention
Duloxetine +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00062673
NCT00062673Phase 3Completed
CompareCT.gov

Duloxetine Versus Placebo in the Treatment of Elderly Patients With Major Depressive Disorder

Eli Lilly and Company·interventional·Posted Jun 12, 2003·Updated May 21, 2007

In Brief

A Phase 3 clinical trial evaluating Duloxetine and Placebo for Depression and Cognition. Completed, across 1 site.

Detailed Summary

A study of the safety and efficacy of duloxetine in elderly patients (greater than 65 years old) with major depressive disorder

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDepression, Cognition
CountriesUnited States
Collaborators--

Timeline

Phase 3CompletedFinished
2003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJun 12, 2003
Enrollment StartMar 1, 2003
Study CompletionJul 1, 2004
TodayJul 2, 2026
Posted 23.1 years ago

Interventions

Duloxetinedrug

Placebodrug